Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Clinical trial NCT04655755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04655755
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-19
- Primary completion
- 2028-07-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.